We are evaluating the long-term safety of inhaled treprostinil for individuals with fibrotic lung diseases. This study is for those who have previously participated in related trials and need ongoing treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Lung fibrosis, also known as interstitial lung disease, is a condition where lung tissue becomes scarred and stiff, making it difficult to breathe. This can lead to symptoms such as shortness of breath, a persistent dry cough, and fatigue.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
